Table 1.
Demographic data on cases pooled for proteomics analysis.
| Sample | Case # | primary NP dx1 | secondary NP dx | Tertiary NP dx | PMI2 | Age death | APOE3 | BRAAK | CERAD | race/gender4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Control 1 | E06-41 | CTL | 10 | 57 | E3/3 | 2 | Normal | wm | ||
| Control 2 | OS00-06 | CTL | 8 | 60 | E3/4 | 0 | Normal | bf | ||
| Control 3 | OS01-112 | CTL | 6 | 65 | E3/3 | 1 | Normal | wf | ||
| Control 4 | A87-50 | CTL | 10 | 66 | E3/3 | 2 | Normal | wm | ||
| Control 5 | OS03-299 | CTL | hemorrhagic infarcts | diffuse plaques | 6 | 69 | E3/3 | 2 | Normal | wm |
| AD 1 | E07-69 | AD | 6 | 58 | E3/4 | 6 | Definite AD | wf | ||
| AD 2 | E05-67 | AD | 11.5 | 62 | E3/4 | 5 | Definite AD | wm | ||
| AD 3 | E04-17 | AD | 9 | 64 | E3/4 | 5/6 | Definite AD | wm | ||
| AD 4 | E05-04 | AD | 4.5 | 64 | E3/4 | 6 | Definite AD | wf | ||
| AD 5 | E05-56 | AD | 17 | 71 | E3/4 | 6 | Definite AD | wm | ||
1
NP dx = neuropathological diagnosis.
2
PMI = postmortem interval.
3
Apolipoprotein E (APOE) genotype.
4
w = white; b= black; m=male; f=female.